Jiangsu Hengrui Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CISATRACURIUM BESYLATE, USP, NON-STERILE, BULK DRUG SUBSTANCE, with a corresponding US DMF Number 25511.
Remarkably, this DMF maintains an Active status since its submission on November 17, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 27, 2015, and payment made on July 17, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II